Management of End Stage Renal Disease-Bangladesh Perspective
Harun Ur Rashid*
Identifiers and Pagination:Year: 2014
First Page: 108
Last Page: 112
Publisher ID: TOUNJ-7-108
Article History:Received Date: 26/6/2014
Revision Received Date: 17/7/2014
Acceptance Date: 17/7/2014
Electronic publication date: 31 /10/2014
Collection year: 2014
open-access license: This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
End stage renal disease (ESRD) is an important cause of morbidity and mortality throughout the world. The treatment of renal replacement therapy (RRT) for patients with ESRD is expensive. There is a direct relationship between per capita income and treatment of ESRD. Eighty five per cent of the world’s population lives in low income or middle-income countries, where the mortality is highest in patients with chronic kidney disease.
The future perspective is not satisfactory for Bangladesh where treatment of ESRD is out of reach for majority of people. Effort should made for prevention and treatment of CKD at an initial stage of disease.